{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T20:26:20Z","timestamp":1761164780593,"version":"build-2065373602"},"reference-count":7,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejpn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Paediatric Neurology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.ejpn.2021.11.007","type":"journal-article","created":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T05:37:07Z","timestamp":1637127427000},"page":"A2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Editorial commentary on \u201cGait phenotype in Batten disease: A marker of disease progression\u201d"],"prefix":"10.1016","volume":"35","author":[{"given":"Nicolas J.","family":"Abreu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily C.","family":"de los Reyes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpn.2021.11.007_bib1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/s41582-019-0138-8","article-title":"Therapeutic landscape for Batten disease: current treatments and future prospects","author":"Johnson","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ejpn.2021.11.007_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpn.2021.09.004","article-title":"Gait Phenotype in Batten disease: a marker of disease progression","author":"Ostergaard","year":"2021","journal-title":"Eur. J. Paediatr. Neurol."},{"issue":"2","key":"10.1016\/j.ejpn.2021.11.007_bib3","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.gene.2016.08.031","article-title":"Analysis of large-scale whole exome sequencing data to determine the prevalence of genetically-distinct forms of neuronal ceroid lipofuscinosis","volume":"593","author":"Sleat","year":"2016","journal-title":"Gene"},{"volume":"vol. 65","year":"2005","author":"Marshall","key":"10.1016\/j.ejpn.2021.11.007_bib4"},{"key":"10.1016\/j.ejpn.2021.11.007_bib5","doi-asserted-by":"crossref","DOI":"10.1177\/2326409818788382","article-title":"An adapted clinical measurement tool for the key symptoms of CLN2 disease","volume":"6","author":"Wyrwich","year":"2018","journal-title":"J Inborn Errors Metab Screen"},{"issue":"3","key":"10.1016\/j.ejpn.2021.11.007_bib6","doi-asserted-by":"crossref","first-page":"E293","DOI":"10.1212\/WNL.0000000000007773","article-title":"Motor function impairment is an early sign of CLN3 disease","volume":"93","author":"Kuper","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.ejpn.2021.11.007_bib7","doi-asserted-by":"crossref","first-page":"101789","DOI":"10.1016\/j.pneurobio.2020.101789","article-title":"A multimodal approach to identify clinically relevant biomarkers to comprehensively monitor disease progression in a mouse model of pediatric neurodegenerative disease","volume":"189","author":"Johnson","year":"2020","journal-title":"Prog. Neurobiol."}],"container-title":["European Journal of Paediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379821002002?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379821002002?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T18:40:41Z","timestamp":1761072041000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090379821002002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":7,"alternative-id":["S1090379821002002"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpn.2021.11.007","relation":{},"ISSN":["1090-3798"],"issn-type":[{"type":"print","value":"1090-3798"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Editorial commentary on \u201cGait phenotype in Batten disease: A marker of disease progression\u201d","name":"articletitle","label":"Article Title"},{"value":"European Journal of Paediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpn.2021.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Ltd on behalf of European Paediatric Neurology Society.","name":"copyright","label":"Copyright"}]}}